SCHEMBL4746938

SCHEMBL4746938

Cc1ccc(C(Br)C=O)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.40
CCR5 P51681 1/20 0.40
CCR8 P51685 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
RAB9A P51151 2/20 0.35
MAPT P10636 1/20 0.35
CYP2A6 P11509 2/20 0.33
S1PR2 O95136 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR3 Q99500 1/20 0.33
CYP3A4 P08684 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 1/20 0.32
ADRA2A P08913 2/20 0.32
ADRA2B P18089 2/20 0.32
ADRA2C P18825 2/20 0.32
PLAU P00749 1/20 0.32
METAP2 P50579 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21495093 1.00 CCR1 (0.40) CCR1CCR5CCR8HDAC6NOS3
SCHEMBL27668675 0.78 CCR1 (0.41) CCR1CCR5CCR8HDAC6NOS3
SCHEMBL4436320 0.78 ALDH1A1 (0.38) RAB9AS1PR2S1PR4S1PR3KDM4E
SCHEMBL26126120 0.77 CCR1 (0.40) CCR1CCR5CCR8HDAC6NOS3
SCHEMBL12050481 0.77 CCR1 (0.40) CCR1CCR5CCR8HDAC6NOS3
SCHEMBL16601086 0.77 ESR1 (0.45)
SCHEMBL22775197 0.77 APLNR (0.41) HDAC6ALDH1A1
SCHEMBL1849724 0.77 APLNR (0.41) HDAC6ALDH1A1
SCHEMBL13859277 0.77 L3MBTL1 (0.35) S1PR2S1PR4S1PR3
Bromide SCHEMBL5196642 0.77 ALDH1A1 (0.37) S1PR2S1PR4S1PR3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed
WO-2008118327-A1 CONFORMATIONALLY RESTRAINED EPOTHILONE ANALOGUES AS ANTI-LEUKEMIC AGENTS UNIVERSITY OF TOLEDO (US) 2008-10-02 WO disclosed
WO-2007015929-A2 EPOTHILONE ANALOGUES UNIVERSITY OF TOLEDO (US) 2007-02-08 WO disclosed